The Oncology Institute's Leadership Expansion
The Oncology Institute, Inc. (NASDAQ: TOI) recently made a notable addition to its executive team by appointing Kristin England as its Chief Administrative Officer (CAO). This new role comes at a crucial moment as the company continues to expand its influence in oncology. Effective July 7, 2025, England will be responsible for overseeing Enterprise Central Business Operations along with Technology Strategy and Enablement across The Oncology Institute’s growing national presence.
Kristin England's Experience and Contributions
With over 20 years of extensive experience in healthcare management and operations, England comes from a distinguished position at McKesson's US Oncology Network. There, she demonstrated her prowess by leading successful teams focused on enhancing revenue cycle performance and optimizing the management of clinical practices. Her commitment to operational efficiency has been a driving force in her previous roles.
Insights from The Oncology Institute's CEO
Daniel Virnich, the CEO of The Oncology Institute, expressed enthusiasm about England's arrival. He remarked, "We’re thrilled to welcome Kristin to our senior leadership team at such a pivotal time for TOI. Her remarkable track record in operational excellence will be vital as we scale our MSO model and deepen our commitment to value-based care." This sentiment echoes the overall excitement within the organization regarding the strategic direction England will contribute to.
England's Vision for The Oncology Institute
In her own words, England indicated her eagerness to join the organization at such a transformative time. She emphasized her commitment to advancing the strategic priorities of The Oncology Institute, aiming to support its ongoing growth through operational excellence and disciplined execution. England’s vision aligns closely with TOI’s mission to create a sustainable healthcare model that better serves patients.
About The Oncology Institute
The Oncology Institute has been pioneering advancements in oncology care since its establishment in 2007. By offering specialized, evidence-based cancer care in community settings, TOI is positioned as a leader in the field. The organization serves over 1.8 million patients, providing access to clinical trials, transfusion services, and other essential healthcare services. With a workforce that includes over 120 clinicians and more than 700 dedicated team members spread across more than 70 clinics, The Oncology Institute is committed to transforming the landscape of cancer care.
Contact Information
For media inquiries, reach out to The Oncology Institute’s Media team at marketing@theoncologyinstitute.com.
For investor relations, please contact Solebury Strategic Communications at investors@theoncologyinstitute.com.
Frequently Asked Questions
Who is Kristin England?
Kristin England is the newly appointed Chief Administrative Officer of The Oncology Institute, responsible for Enterprise Central Business Operations and Technology Strategy.
What was Kristin England’s previous role?
Before joining The Oncology Institute, Kristin England was a senior executive at McKesson’s US Oncology Network, where she led initiatives in revenue cycle performance.
Why is Kristin England's appointment significant?
Her experience in enhancing operational efficiency is anticipated to play a crucial role in supporting The Oncology Institute’s growth and strategic initiatives.
What is the focus of The Oncology Institute?
The Oncology Institute specializes in delivering evidence-based oncology care in community settings, serving over 1.8 million patients with innovative treatment options.
How can I contact The Oncology Institute?
Media inquiries can be directed to marketing@theoncologyinstitute.com, while investor relations can be reached at investors@theoncologyinstitute.com.
